A citation-based method for searching scientific literature

Ranjit Manchanda, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba, Adam Brentnall, Stephen Duffy, Bin Cui, Patricia Coelho De Soarez, Zakir Husain, John Hopper, Zia Sadique, Asima Mukhopadhyay, Li Yang, Johannes Berkhof, Rosa Legood. Cancers (Basel) 2020
Times Cited: 6







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Tara M Friebel, Eitan Friedman, Ute Hamann, Dezheng Huo, Ava Kwong, Edith Olah, Olufunmilayo I Olopade, Angela R Solano, Soo-Hwang Teo,[...]. Hum Mutat 2018
106
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
33

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
33

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
33

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
491
33

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
33

Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.
Marcelo Cristiano de Azevedo Ramos, Maria Aparecida Azevedo Koike Folgueira, Simone Maistro, Alessandro Gonçalves Campolina, Patricia Coelho de Soárez, Geertruida Hendrika de Bock, Hillegonda Maria Dutilh Novaes, Maria Del Pilar Estevez Diz. Rev Saude Publica 2018
6
33

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
56
33

Population-based genetic testing for Women's cancer prevention.
Olivia Evans, Faiza Gaba, Ranjit Manchanda. Best Pract Res Clin Obstet Gynaecol 2020
5
40


Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
Ranjit Manchanda, Kelly Loggenberg, Saskia Sanderson, Matthew Burnell, Jane Wardle, Sue Gessler, Lucy Side, Nyala Balogun, Rakshit Desai, Ajith Kumar,[...]. J Natl Cancer Inst 2014
102
33

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Li Sun, Adam Brentnall, Shreeya Patel, Diana S M Buist, Erin J A Bowles, D Gareth R Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey,[...]. JAMA Oncol 2019
31
33


Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
335
16

Serous tubal intraepithelial neoplasia: the concept and its application.
Emily E K Meserve, Jan Brouwer, Christopher P Crum. Mod Pathol 2017
36
16

Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis.
T Rinda Soong, David L Kolin, Nathan J Teschan, Christopher P Crum. Cancers (Basel) 2018
15
16

Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
F Chen, K Gaitskell, M J Garcia, A Albukhari, J Tsaltas, A A Ahmed. BJOG 2017
36
16


Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
Marline G Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H E M Maas, Judith B Prins, Johan Bulten, Steven Teerenstra, Eddy M M Adang, Jurgen M J Piek, Helena C van Doorn,[...]. BMC Cancer 2015
54
16

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
66
16

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Denise R Nebgen, Jean Hurteau, Laura L Holman, Andrea Bradford, Mark F Munsell, Beth R Soletsky, Charlotte C Sun, Gary B Chisholm, Karen H Lu. Gynecol Oncol 2018
27
16

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
16

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
702
16

Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
Marieke Arts-de Jong, Marline G Harmsen, Nicoline Hoogerbrugge, Leon F Massuger, Rosella P Hermens, Joanne A de Hullu. Gynecol Oncol 2015
23
16


Incidence of sexual dysfunction in surgically menopausal women.
J L Shifren, R Nahum, N A Mazer. Menopause 1998
17
16

Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
M J A Kenkhuis, G H de Bock, P Oude Elferink, H J G Arts, J C Oosterwijk, L Jansen, M J E Mourits. Maturitas 2010
19
16

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013
103
16

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
16

Vasomotor flushes in menopausal women.
G A Bachmann. Am J Obstet Gynecol 1999
131
16

The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
Thing Rinda Soong, Brooke E Howitt, Neil Horowitz, Marisa R Nucci, Christopher P Crum. Gynecol Oncol 2019
32
16

Completeness of salpingectomy intended for ovarian cancer risk reduction.
Jennifer W H Wong, Jeffrey L Killeen, Michael E Carney. Gynecol Oncol 2019
2
50

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
Michelle R Jones, Daniella Kamara, Beth Y Karlan, Paul D P Pharoah, Simon A Gayther. Gynecol Oncol 2017
34
16


Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.
Tomas Riman, Paul W Dickman, Staffan Nilsson, Nestor Correia, Hans Nordlinder, Cecilia M Magnusson, Ingemar R Persson. Am J Epidemiol 2002
146
16

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
712
16

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
706
16

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
127
16


Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.
Laura L Holman, Sue Friedman, Molly S Daniels, Charlotte C Sun, Karen H Lu. Gynecol Oncol 2014
49
16

Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.
Janice S Kwon, Jessica N McAlpine, Gillian E Hanley, Sarah J Finlayson, Trevor Cohen, Dianne M Miller, C Blake Gilks, David G Huntsman. Obstet Gynecol 2015
71
16

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
Walter A Rocca, Brandon R Grossardt, Mariza de Andrade, George D Malkasian, L Joseph Melton. Lancet Oncol 2006
329
16

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
287
16

Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Henrik Falconer, Li Yin, Henrik Grönberg, Daniel Altman. J Natl Cancer Inst 2015
205
16

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
Jessica N McAlpine, Gillian E Hanley, Michelle M M Woo, Alicia A Tone, Nirit Rozenberg, Kenneth D Swenerton, C Blake Gilks, Sarah J Finlayson, David G Huntsman, Dianne M Miller. Am J Obstet Gynecol 2014
164
16

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
348
16

Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere.
Michele Morelli, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Erika Rania, Daniela Lico, Pietro D'Alessandro, Fulvio Zullo. Gynecol Oncol 2013
131
16

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
16

The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report.
G N Marta, D Ramiah, O Kaidar-Person, A Kirby, C Coles, R Jagsi, T Hijal, G Sancho, Y Zissiadis, J-P Pignol,[...]. Clin Oncol (R Coll Radiol) 2021
5
20

[Breast Cancer: Value-Based Healthcare, Costs and Financing].
Ana Harfouche, Silvia Silva, João Faria, Rui Araújo, António Gouveia, Maria Lacerda, Luís D'Orey. Acta Med Port 2017
4
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.